[ad_1] Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene’s onCARlytics (CF33-CD19) oncolytic virus and JW’s CD19 CAR-T cell therapy, Carteyva®, in refractory solid […]
Real-time disaster intelligence, alerts, and response tools.
Sunday, May 10, 2026
#Rosal Top Picks
Recent Posts
- [ad_1] HEFEI, China, Jan. 8, 2026 /PRNewswire/ —
- [ad_1] Regulation 36 of the Securities Regulations
- [ad_1] LAUSANNE, Switzerland, Jan. 8, 2026
- [ad_1] Single-Family Development Will Add 144
- [ad_1] Morning routines just got more delicious with
